Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three‐group matching weights
Authors:
- Kazuki YoshidaKYKazuki Yoshida
- Zhi YuZYZhi Yu
- Gail A. GreendaleGGGail A. Greendale
- Kristine RuppertKRKristine Ruppert
- Sara K. TedeschiSara K. Tedeschi
- Tzu‐Chieh LinTLTzu‐Chieh Lin
- Sebastien HaneuseSHSebastien Haneuse
- Robert J. GlynnRGRobert J. Glynn
- Sonia Hernández‐DíazSHSonia Hernández‐Díaz
- Daniel H. SolomonDSDaniel H. Solomon
Open Access
- 12 December 2017
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 27 (2) , 182-190
Abstract
Purpose: To examine the effects of analgesics on bone mineral density (BMD), which have not been examined in a longitudinal study with multiple measurements.Methods: We investigated changes in BMD associated with new use of analgesics in a prospective longitudinal cohort of mid‐life women. BMD and medication use were measured annually. We compared BMD among new users of acetaminophen, NSAIDs, and opioids. Adjustment for baseline covariates was conducted through propensity score matching weights. On‐treatment analysis was conducted with inverse probability of censoring weights. Analysis based on the initial treatment group was also conducted to provide insights into selection bias. Repeated BMD measurements were examined with generalized estimating equations.Results: We identified 71 acetaminophen new users, 659 NSAID new users, and 84 opioid new users among 2365 participants. In the on‐treatment analysis, the opioid group in comparison to the acetaminophen group had an additional average BMD decline of −0.06% [−1.24, 1.11] per year in the spine and −0.45% [−1.51, 0.61] per year in the femoral neck. BMD mean trajectories over time suggested a fifth‐year decline in the opioid persistent users compared with other 2 groups. In the initial treatment group analysis, all 3 groups showed similar trajectories.Conclusion: The BMD decline over time was similar among the 3 groups. However, 5 years of continuous opioid use may be associated with a greater BMD decline than 5 years on other analgesics. Further studies examining the relationship between very long‐term persistent opioid use and BMD are warranted.Keywords
Funding Information
- United States National Institute on Aging
- National Institute of Nursing Research (NINR) and the National Institute of Health Office of Research on Women's Health (U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495)
This publication has 48 references indexed in Scilit:
- Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN)Journal of Bone and Mineral Research, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Opioid Analgesics and the Risk of Fractures in Older Adults with ArthritisJournal of the American Geriatrics Society, 2011
- Prostaglandins in bone: bad cop, good cop?Trends in Endocrinology & Metabolism, 2010
- Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain PatientsJournal of General Internal Medicine, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Antihistamine Therapy and Bone Mineral Density: Analysis in a Population-Based US SampleThe American Journal of Medicine, 2008
- Causal Inference from Longitudinal Studies with Baseline RandomizationThe International Journal of Biostatistics, 2008
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992